Search This Blog

Tuesday, May 19, 2026

Boston Scientific trial for SEISMIQ 4CE coronary intravascular lithotripsy catheter meets endpoints

 

Boston Scientific's FRACTURE IDE trial for SEISMIQ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints

  • FRACTURE IDE results provide key data to support a planned regulatory submission for the SEISMIQ 4CE catheter.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)